Company Description
Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally.
It operates through Dental and Medical segments. The company provides the Wand, a single use disposable handpiece device for dental procedures that require local anesthetic under the CompuDent and STA Single Tooth Anesthesia System names.
It also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection.
In addition, the company provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications.
Further, it offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines.
Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.
| Country | United States |
| Founded | 1989 |
| IPO Date | Nov 3, 1995 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 17 |
| CEO | Neal Goldman |
Contact Details
Address: 425 Eagle Rock Avenue, Suite 403 Roseland, New Jersey 07068 United States | |
| Phone | 973 535 2717 |
| Website | milestonescientific.com |
Stock Details
| Ticker Symbol | MLSS |
| Exchange | NYSEAMERICAN |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000855683 |
| CUSIP Number | 59935P209 |
| ISIN Number | US59935P2092 |
| Employer ID | 13-3545623 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Neal Ira Goldman CFA | Chairman of the Board and Interim Chief Executive Officer |
| Leonard A. Osser | Founder and Vice Chairman |
| Jan Adriaan Haverhals | Director |
| James Hippett J.D. | Senior Vice President of Global Sales and Business Development |
| Keisha Harcum | Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 22, 2025 | 144 | Filing |
| May 19, 2025 | 8-K | Current Report |
| May 15, 2025 | 10-Q | Quarterly Report |
| Apr 22, 2025 | 8-K | Current Report |
| Apr 15, 2025 | 10-K | Annual Report |
| Mar 28, 2025 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
| Feb 7, 2025 | SCHEDULE 13D/A | Filing |
| Jan 13, 2025 | 8-K | Current Report |
| Dec 20, 2024 | 8-K | Current Report |
| Dec 19, 2024 | 144 | Filing |